Cutoff levels of 17-alpha-hydroxyprogesterone in neonatal screening for congenital adrenal hyperplasia should be based on gestational age rather than on birth weight. [electronic resource]
- The Journal of clinical endocrinology and metabolism Jul 2005
- 3904-7 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
0021-972X
10.1210/jc.2004-2136 doi
17-alpha-Hydroxyprogesterone--blood Adrenal Hyperplasia, Congenital--diagnosis Birth Weight Gestational Age Humans Infant, Newborn Neonatal Screening Regression Analysis Sensitivity and Specificity